Rare cancer registry study in Korea
Part of Cancer clinical trials.
This study collects information about people with rare cancers in Korea to better understand these diseases. It may help improve future care and treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older.
- You have been diagnosed with a rare cancer.
- You are expected to live at least 3 more months.
- You do not have any serious or unstable medical or mental health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a research study that builds a registry (a record) of women in Korea with cervical, endometrial, or ovarian cancer. It may help researchers better understand these cancers and plan future studies.
This study follows breast cancer patients who are scheduled to receive radiotherapy at a National Cancer Center in Korea. By collecting information during and after treatment, researchers hope to better understand how patients do over time.
This is a study that collects information about people with rare cancers (or cancers where the source is unknown) and advanced-stage cancer. It helps researchers build a knowledge database to improve understanding and care for these cancers in Asia.
This trial is creating a registry for very rare solid tumors in people up to age 39. Joining helps doctors learn more about these cancers and may connect you with future research opportunities.
This study collects information from children and teens with rare solid tumors to better understand these cancers and support future research. You (or your guardian) can join by giving consent, but it’s mainly for people not already registered in certain ongoing pediatric cancer study databases in Germany.
This study is looking at children and teens with very rare tumors to learn more about these conditions and improve future care. It aims to gather information from patients treated at participating centers.
Hear when a new Rare Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.